Short seller Andrew Left of Citron Research revealed on Nov. 21 that his firm had taken a short position in MicroStrategy ...

The S&P 500 shattered records again, closing above 6,000 for only the second time in its history. Tuesday’s session saw the ...

According to Google Finance data, MicroStrategy shares have dropped to ~$353, down 34% from Nov. 21st’s high of ~$535. The ...

Based on analysis from Wall Street investment firm Bernstein, the iShares Bitcoin Trust could soar another 100% in 2025. The ...

Anthony Pompliano has joined Solana holding company Sol Strategies as an advisor. Is a Nasdaq listing looming for the company ...

Bernstein analysts predict MicroStrategy will own 4% of the total bitcoin supply by the end of 2033, an amount they expect to ...

MicroStrategy buys more bitcoin, and Benchmark analyst’s new Street-high stock price target implies more than 60% upside.

Cambridge, Massachusetts-based Biogen Inc. ( BIIB) discovers, develops, manufactures, and delivers therapies for treating ...

Bernstein raised the firm’s price target on MicroStrategy (MSTR) to $600 from $290 and keeps an Outperform rating on the shares.

MicroStrategy (NASDAQ:MSTR) bought ~55,500 more bitcoins for ~$5.4B in the week of Nov. 18-24, an ~17% increase in its ...

Investors should be cautious around speculative, high-yield ETFs. Read why investors instead should rely on reliable dividend ...